Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-004 Berry Genomics Co.Ltd(000710)
On the stock pledge repurchase transaction conducted by the controlling shareholders and their persons acting in concert
Announcement of supplementary pledge and deferred repurchase
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Berry Genomics Co.Ltd(000710) (hereinafter referred to as “the company”) recently received a notice from Mr. Gao Yang, the controlling shareholder of the company, and Ms. Hou Ying, the person acting in concert. It was learned that Mr. Gao Yang and Ms. Hou Ying, the person acting in concert, have gone through the procedures of supplementary pledge and deferred repurchase of stock pledge type repurchase transaction. After verification with the pledgee and consulting the relevant data issued by China depository and Clearing Co., Ltd., the specific matters are confirmed as follows: I. supplementary pledge
Whether it is the largest supplementary shareholder of this supplementary pledge. When the supplementary pledge is due, the pledge accounts for the name of the pledge shareholder and the date of the Pledged Shares. The proportion of the shares held by the pledgee in the number (shares) of the same bank of the company and the proportion of the total share capital
Gaoyang is a 64500002021.12.312022.5.17 Guosen Securities Co.Ltd(002736) 16.0008% 1.8189% limited company
Hou Ying is a limited company with 200000020222.1.42022.5.17 Guosen Securities Co.Ltd(002736) shares of 8.5632% and 0.5640%
Total – 8450000 – 13.2723% 2.3829%
2、 Basic information of deferred repurchase
Is it this time
The largest shareholder of the company, the deferred pledge right of the deferred purchase pledge accounts for its share
Name of shareholder and repurchase of Pledged Shares to the date when the total share capital held by the repurchaser is used for the same purpose number of lines (shares) date proportion
moving
2017.2021.2022. Guoxin personal 239200008.178.125.17 securities 59.34% 6.75% financial management Gaoyang is the demand for shares, 2600002017.2021.2022 Limited 0.64% 0.07% supplement 12.1512.3012.30 company pledge
Subtotal – 2418000 – 59.98% 6.82%
Hou Ying is 139600000217.2021.2022 Guosen 59.77% 3.94% personal 8.178.175.17 securities finance
Share demand, supplementary pledge of limited company
Total – 38140000 – 59.91% 10.76%
3、 Cumulative pledge
As of the date of this announcement, the controlling shareholder Mr. Gao Yang holds 40310572 shares of the company, accounting for 11.37% of the total share capital of the company. The company’s shares held by him have been pledged 2418000 shares, accounting for 59.98% of the total shares held by him and 6.82% of the total share capital of the company.
As of the date of this announcement, Ms. Hou Ying, the person acting in concert, holds 23355661 shares of the company, accounting for 6.59% of the total share capital of the company. The company’s shares held by him have been pledged 13960000 shares, accounting for 59.77% of the total shares held by him and 3.94% of the total share capital of the company.
As of the date of this announcement, Mr. Gao Yang, the controlling shareholder of the company, and Ms. Hou Ying, the person acting in concert, held 63666233 shares of the company, accounting for 17.95% of the total share capital of the company. 38140000 shares of the company were pledged, accounting for 59.91% of the total shares of the company and 10.76% of the total share capital of the company.
4、 Other relevant instructions
1. Mr. Gao Yang is going through supplementary pledge procedures for early pledge repurchase transactions, and Mr. Gao Yang and Ms. Hou Ying, who acted in concert, are going through deferred repurchase procedures for Pledged Shares, which does not involve new financing and new pledge arrangements.
2. As of the date of this announcement, Mr. Gao Yang and Ms. Hou Ying, who acted in concert, are in good credit condition and have the ability to perform the contract. The shares pledged by Mr. Gao Yang and Ms. Hou Ying, the person acting in concert, do not have the risk of closing positions, will not lead to the change of the company’s actual control, and will not have a significant adverse impact on the company’s production, operation and financial status.
3. The company will continue to pay attention to its pledge and pledge risk, and timely perform the obligation of information disclosure as required. Please pay attention to the investment risk.
5、 Documents for future reference
1. Detailed statement of securities pledge and judicial freezing of China Securities Depository and Clearing Co., Ltd.
2. Confirmation of stock pledge repurchase and deferred repurchase transaction. 3. Confirmation of stock pledge repurchase supplementary pledge transaction. It is hereby announced.
Berry Genomics Co.Ltd(000710) board of directors January 5, 2022
